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A B S T R A C T
Objective. The objective of this study was to (1) describe the technical aspects of fluoroscopy-guided umbilical
venous catheter placement (FGUVCP); and (2) determine the procedural success rate, factors contributing to
procedural failure, and risks of the procedure.
Background. Umbilical venous catheters are advantageous compared with femoral venous access, but can be
difficult to place at the bedside.
Materials and Methods. This was a retrospective chart review from a single tertiary care referral institution.
Results. FGUVCP was successful in 138 of 180 patients (76.7%) over a seven-year period. Patients in whom
FGUVCP was successful were younger at the time of procedure compared with patients in whom FGUVCP was
unsuccessful (median 18.2 vs. 22.2 hours, P = .03). The optimal age cutoff to predict FGUVCP success was 20 hours
with a high positive predictive value (82.4%) but low negative predictive value (32.5%). No other variables were
associated with procedural failure, though functional univentricular heart and older gestational age trended toward
statistical significance. Median radiation time, contrast exposure, and blood loss were 3.2 minutes, 1 mL, and 1 mL,
respectively. A total of 10 complications in 10 patients were associated with FGUVCP.
Conclusions. FGUVCP is a safe and highly successful way to obtain central venous access in neonates with
congenital heart disease. Older age at the time of procedure is associated with procedural failure, but utilization of
an age cutoff may not be clinically useful.
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Introduction
Many infants with congenital heart defectswill require surgery in the neonatal period.
Central venous access is useful in these patients for
hemodynamic monitoring and medication admin-
istration both before and after surgery. While the
typical routes of central venous access—the
femoral, internal jugular, and subclavian veins—
are available in this population, neonates have a
unique route of access: the umbilical vein.
In fetal circulation, the umbilical vein trans-
ports oxygen rich blood from the placenta through
the liver via the ductus venosus to the inferior vena
cava. Postnatally, the umbilical vein maintains its
connection to the central circulation, provided the
ductus venosus remains open.1,2 Typically, umbili-
cal venous catheters (UVCs) can be directly
inserted into the umbilical stump and advanced
into the right atrium via the ductus venosus at the
bedside. Successful placement is typically con-
firmed by frontal chest/abdomen bedside radio-
graphs with the tip of the catheter projecting
above the right hemi-diaphragm (in patients with
abdominal situs solitus).
When UVC placement is unsuccessful, it is
usually because the catheter does not cross the
Work was performed at the University of Michigan C.S.
Mott Children’s Hospital.
This study was performed with funding from the Divi-
sion of Pediatric Cardiology fellowship general research
funds.
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ductus venosus and deflects into the portal circu-
lation.3 Fortunately, UVC placement is successful
about half of the time on first attempt using the
standard technique of manual insertion.4,5 Various
maneuvers have been described, such as the
double catheter technique4,6–8 and posterior liver
mobilization,5 which can increase the ultimate
success rate to approximately 75%. Other imaging
modalities, such as ultrasound9–12 and electrocar-
diography,13 can help determine the location of the
catheter tip, but do not increase success rates. Of
course, if the ductus venosus closes prior to UVC
placement, the procedure will be unsuccessful, but
no bedside UVC placement technique currently
described in the literature determines its patency.
UVCs are relatively safe in the short term as
long as they are placed correctly.4,14 In a recent
review of neonates after congenital heart surgery
from University of Michigan C.S. Mott Children’s
Hospital, Aiyagari et al. demonstrated superior
safety of UVCs compared with femoral venous
catheters and a high success rate for UVC place-
ment.15 This review generated considerable inter-
est in the techniques employed at our institution
prompting a review of our practice. For over 20
years, pediatric cardiologists have been developing
the technique of fluoroscopy-guided UVC place-
ment (FGUVCP) in the cardiac catheterization
laboratories at our institution. In this report, we
describe this previously unpublished technique.
Furthermore, by reviewing patient and procedural
data from a substantial sample of neonates in
whom FGUVCP was attempted, we describe our
success rate, determine what factors contribute to
procedural failure, and identify the risks of the
procedure. In particular, we aim to understand
how age at procedure impacts success rate, as age
is the only truly modifiable factor.
Materials and Methods
Study Description
All patients in whom placement of an UVC was
attempted in the University of Michigan Congeni-
tal Heart Center catheterization laboratories
between November 1, 2005 and November 30,
2012 were included. Five attending physicians per-
formed this procedure during this time period.
The study was approved with a waiver of informed
consent by our institutional review board.
Patients were identified by search of the cath-
eterization laboratory logbooks and software
systems (WITT Biomedical Calysto Series IV and
Xper Information Management, Philips, Best,
The Netherlands) and procedural reports were
reviewed. If review of the procedural log and
report indicated that FGUVCP was attempted,
the patient’s UVC status on arrival to the catheter-
ization laboratory was noted. If the patient had an
appropriately placed UVC on arrival which was
exchanged to facilitate a diagnostic or interven-
tional procedure, the patient was excluded from
the study. If the patient had failed bedside UVC
placement, had prior successful bedside UVC
placement but the UVC had been inadvertently
withdrawn from the central circulation, or had not
had bedside UVC placement attempted, further
demographic and procedural data were collected.
These included date and time of birth, gestational
age, date and time of procedure, procedure length,
cardiac diagnosis, periprocedure prostaglandin
use, presence of heterotaxy syndrome, fluoroscopy
time, iodinated contrast use, blood loss, additional
procedures performed, complications of the pro-
cedure(s), result of angiogram (if applicable), and
whether or not FGUVCP was successful.
Two cohorts were created for data analysis. The
first cohort comprised all subjects who met inclu-
sion criteria. This cohort was analyzed to deter-
mine FGUVCP success rate and to determine the
effects of patient characteristics on that success
rate. The second cohort was created to determine
procedural data including fluoroscopy time, iodi-
nated contrast dose, and procedural blood loss
attributable to FGUVCP. It comprised only those
subjects without an additional procedure (e.g.,
percutaneous balloon atrial septostomy) with two
exceptions: (1) subjects who had umbilical artery
catheter (UAC) replacement if it was dislodged by
FGUVCP (as UAC dislodgement was considered
a complication of FGUVCP); and (2) subjects in
whom FGUVCP was unsuccessful and central
venous access was attempted at another site.
FGUVCP Technique
Institutional practice is to attempt UVC place-
ment at the bedside if an emergent intervention is
not necessary. Most often, this is performed by the
neonatal team in the neonatal intensive care unit
for patients born at the C.S. Mott Children’s Hos-
pital or by the neonatal team at a referring insti-
tution. Less often, UVC placement occurs in our
institution’s pediatric cardiothoracic intensive care
unit. The techniques used to enhance successful
bedside placement (e.g., double catheter tech-
nique, posterior liver mobilization, etc.) are vari-
able and dependent on the experience of the
provider placing the catheter.
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When bedside UVC placement is unsuccessful,
the catheter is withdrawn, secured at 5 cm in a
“low-lying” position, and FGUVCP is scheduled
if requested by the cardiac intensivist. After
obtaining informed consent from the parents or
guardians, the patient is brought to the catheter-
ization laboratory and placed supine on the cath-
eterization table. If no other procedures are
deemed necessary, this procedure is performed
without sedation or with light sedation.
After antiseptic preparation and sterile draping
of the umbilical region, a new 5 French double- or
triple-lumen UVC is prepared by flushing all
lumens with heparinized saline. A 3 mL syringe
filled with iodinated contrast is connected to a
secondary lumen of the catheter and flush syringes
are connected to the remaining catheter lumens.
The existing low-lying UVC is removed and the
new UVC is inserted into the umbilical vein. The
new UVC is advanced until light resistance is met.
A steerable 0.018-inch wire such as an angled
Glidewire (Terumo Medical Corporation, Somer-
set, NJ, USA) or a Cope wire (Cook, Blooming-
ton, IN, USA) is advanced into the primary lumen
of the catheter and, under fluoroscopic guidance,
the wire is advanced beyond the catheter tip.
In some cases, the wire will pass across the
patent ductus venosus directly into the right
atrium. If this occurs, the catheter is advanced over
the wire and its tip is positioned at the cavoatrial
junction. The wire is removed from the primary
lumen and blood is withdrawn from all lumens and
the lumens are then flushed. The UVC is then
secured with suture and the procedure is complete.
In most cases, the wire does not gain immediate
access to the right atrium and a small amount of
contrast is injected through the secondary lumen.
Biplane fluoroscopy/angiography is recommended
as the ductus venosus takes a very posteriorly
directed course, which is not readily visualized on
frontal projection (Figure 1A,B). With the course
of the ductus venosus visualized, the wire is used to
cross into the right atrium.
In some cases, the ductus venosus is patent by
contrast venography but is tortuous or of small
caliber, and the UVC does not readily follow the
wire into the right atrium. In these circumstances,
a number of maneuvers can be attempted. One
such maneuver is to serially dilate the tract with 3
French, 4 French, and 5 French dilators. Another
useful maneuver is to replace the initial guidewire
with a stiffer wire. Passing a 0.014-inch guidewire
through an additional lumen of the UVC can also
provide added “stiffness” and facilitate advancing
the catheter. These maneuvers can be used singly
or in combination. Whatever wires are selected
must have a very soft and pliable tip in order to
avoid perforation of the hepatic or cardiac
structures.
If there is no evidence of a patent ductus
venosus by angiography (Figure 1C,D), the proce-
dure is abandoned. Even if the ductus venosus is
in spasm or functionally closed, there is no
“roadmap” for advancing a guidewire. Similarly, if
a wire cannot traverse the ductus venosus, the pro-
cedure is also abandoned. Central venous access at
another site is often attempted if the referring
physician requests and if work flow in the catheter-
ization laboratory permits.
Statistical Analysis
Demographic, clinical, and procedural character-
istics were presented as frequency (%) for cat-
egorical variables and median (interquartile range)
Figure 1. Umbilical vein angiography. Contrast is injected
from the tip of the umbilical venous catheter (black arrows).
In the upper two images, an open ductus venosus can be
seen (white brackets) with a puff of contrast entering the
right atrium (white arrows) in frontal (A) and lateral (B)
projections. In the lower two images, the ductus venosus is
closed and not identified in either frontal (C) or lateral (D)
projections. Note the prominent opacification of the portal
veins that is seen when the ductus venosus is closed (C and
D) compared with when it is open (A and B).
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for continuous variables. Group comparisons
between successful and unsuccessful FGUVCP
were made using chi-square tests or Fisher’s exact
tests, as appropriate, for categorical variables, and
Wilcoxon rank-sum tests for continuous variables.
A receiver operating characteristic (ROC) curve
was generated to determine an optimal age cutoff
for significant discrimination of FGUVCP
success. Odds ratios (ORs) with 95% confidence
intervals (CIs) were also estimated using logistic
regression to evaluate the effect of age at proce-
dure on FGUVCP using the optimal cutoff
obtained from the ROC curve. All analyses were
performed using SAS version 9.3 (SAS Institute,
Cary, NC, USA), with statistical significance set at
P value less than 0.05 using two-sided tests.
Results
Inclusion criteria were met by 180 patients.
Among those, bedside placement had been unsuc-
cessful in 163 patients (90.6%). The first attempt
at UVC placement was in the catheterization labo-
ratory in 11 patients (6.1%), and in 6 patients
(3.3%) FGUVCP was utilized after a previously
well-positioned bedside UVC was noted to have
migrated out of the central circulation. Patient
demographics and clinical characteristics are
shown in Table 1. Additional procedures beyond
FGUVCP were performed in 110 patients, 22 of
whom only had central venous catheter placement
at another site.
Overall, FGUVCP was successful in 138
patients (76.7%) and unsuccessful in 42 patients
(23.3%). In the unsuccessful group, contrast
venography demonstrated patency of the ductus
venosus in 31% of patients (13/42). Among the
patients in whom initial bedside placement was
unsuccessful (N = 163), 122 (74.8%) patients had
successful FGUVCP.
Patients in whom FGUVCP was successful
were younger than those in whom it was unsuc-
cessful (median 18.2 hours vs. 22.2 hours, P = .03)
(Table 1). Precise data needed to determine age at
procedure were missing in nine patients. The
number of patients with successful and unsuccess-
ful FGUVCP by age at procedure is illustrated in
Figure 2. No other patient characteristics were
Table 1. Comparison of Patient and Clinical Characteristics for Neonates by FGUVCP Result (N = 180)
Overall FGUVCP success





Age at procedure, h 19.3 (8.3–32.1) 18.2 (7.5–29.0) 22.2 (14.6–45.8) .03
<20 75 (54.3) 16 (38.1) .02
≥20 54 (39.1) 26 (61.9)
Missing 9 (6.5) 0 (0.0)
<24 89 (64.5) 23 (54.8) .09
≥24 40 (29.0) 19 (45.2)
Missing 9 (6.5) 0 (0.0)
<36 106 (76.8) 29 (69.0) .07
≥36 23 (16.7) 13 (31.0)
Missing 9 (6.5) 0 (0.0)
Male sex 111 (61.7) 84 (60.9) 27 (64.3) .69
Gestational age, wk 39 (38–39.6) 39 (37.9–39.4) 39.2 (38.2–39.7) .07
Preterm (less than 37 wk) 23 (16.7) 4 (9.5) .27
Birth weight, kg 3.2 (2.95–3.5) 3.2 (2.9–3.5) 3.1 (2.9–3.4) .97
Cardiac diagnosis
Functional univentricular heart 86 (47.8) 61 (44.2) 25 (59.5) .08†
Hypoplastic left heart syndrome 48 (26.7) 33 (23.9) 15 (35.7)
Pulmonary atresia with intact ventricular septum 9 (5.0) 8 (5.8) 1 (2.4)
Tricuspid atresia 8 (4.4) 7 (5.1) 1 (2.4)
Unbalanced atrioventricular septal defect 11 (6.1) 7 (5.1) 4 (9.5)
Other 10 (5.6) 6 (4.3) 4 (9.5)
Transposition physiology 38 (21.1) 33 (23.9) 5 (11.9)
Left heart obstructive lesion 21 (11.7) 17 (12.3) 4 (9.5)
Right heart obstructive lesion 19 (10.6) 13 (9.4) 6 (14.3)
Balanced atrioventricular septal defect 2 (1.1) 2 (1.4) 0 (0.0)
Other 14 (7.8) 12 (8.7) 2 (4.8)
Heterotaxy syndrome 15 (8.3) 9 (6.5) 6 (14.3) .12
Receiving prostaglandin infusion 158 (87.8) 121 (87.7) 37 (88.1) .94
Data are presented as N (%) for categorical variables and median (25th–75th percentiles) for continuous variables.
*P value from chi-square test or Fisher’s exact test, as appropriate, for categorical variables, and Wilcoxon rank-sum test for continuous variables.
†Comparison was made between functional univentricular heart vs. all others, and P value was from chi-square test.
FGUVCP, fluoroscopy-guided umbilical venous catheter placement.
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found to have a significant association with
FGUVCP results, though functional univentricu-
lar heart (P = .08) and older gestational age (P =
.07) trended toward association with FGUVCP
failure.
Utilizing the ROC curve, the optimal cutoff for
age at the time of procedure to identify the
patients with procedural success was 20 hours
(area under the curve [AUC] = 0.61) with sensitiv-
ity of 58.1%, specificity of 61.9%, positive predic-
tive value of 82.4%, and negative predictive value
of 32.5%. Patients less than 20 hours of age at
procedure were more likely to have successful
FGUVCP than those with age of 20 hours or
greater (P = .02). Age cutoff of 24 and 36 hours did
not reach statistical significance (P = .09 and .07,
respectively [Table 1]). In multivariate analysis,
when adjusting for cardiac diagnosis, age less than
20 hours at the time of procedure remained sig-
nificantly associated with FGUVCP success (OR
2.36, 95% CI 1.14, 4.86; P = .02) (Table 2).
Procedural data are shown in Table 3 for the
second cohort described above. A total of 114
patients only had central venous line placement, 92
had FGUVCP alone, and 22 had failed FGUVCP
and central venous access at a secondary site. The
median procedure time was 52.0 minutes when
only FGUVCP was attempted and 78.4 minutes
when FGUVCP failed and a central venous cath-
eter was placed at another site. Similarly, fluoros-
copy time, contrast dose, and blood loss were all
low when only FGUVCP was attempted and
slightly higher when FGUVCP failed and a central
venous catheter was placed at another site.
In the entire 180-patient cohort, there were a
total of 17 complications. In seven patients, the
complication was attributed to a non-FGUVCP
portion of the procedure (e.g., bradycardia with
balloon atrial septostomy). Of the remaining 10
complications attributable to FGUVCP, seven
patients had dislodgement of the umbilical arterial
catheter associated with transportation to the
catheterization laboratory or during the procedure
itself. Two patients had transient heart rhythm dis-
turbances (one with hemodynamically insignifi-
cant atrial flutter which self-resolved and one with
complete heart block requiring atropine). Finally,
in one patient, cardiopulmonary resuscitation was
required. According to the report, the patient
“started to cry and appeared to have a breath
holding spell” with subsequent respiratory arrest
and ventricular fibrillation requiring less than 1
minute of compressions. This occurred after the
line was placed and while it was being secured with
suture.
Discussion
In this population of neonates with congenital
heart disease (CHD), FGUVCP is highly success-
ful (76.7%), which is higher than the 50–75% that
is reported in the literature for bedside placement
techniques.4–8 This is an invalid comparison as the
Figure 2. Number of patients with procedural success and
failure after attempted fluoroscopy-guided umbilical venous
catheter placement by age at procedure. Success rates
were 82.1% for patients less than 12 hours of age, 76.8%
for patients 12–24 hours of age, 69.7% for patients 24–48
hours of age, and 65.4% for patients older than 48 hours of
age. Age at procedure data were missing in nine patients,
all of whom had successful umbilical venous catheter
placement.
Table 2. Odds of Successful FGUVCP (N = 180)
Unadjusted Adjusted
OR 95% CI P value* AOR 95% CI P value†
Age at procedure, h
<20 2.26 1.11, 4.61 .02 2.36 1.14, 4.86 .02
≥20 Ref Ref
Cardiac diagnosis
Functional univentricular heart 0.54 0.27, 1.09 .08 0.53 0.26, 1.08 .08
All others Ref Ref
*P value from (unadjusted) logistic regression.
†P value from multivariate logistic regression.
FGUVCP, fluoroscopy-guided umbilical venous catheter placement; OR, (unadjusted) odds ratio; AOR, adjusted odds ratio; CI, confidence interval; Ref, reference.
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true measure of the impact of FGUVCP is the
nearly 75% success rate for the 163 patients in
whom initial bedside placement was unsuccessful.
Unfortunately, the institutional success rate of
standard bedside insertion in CHD patients is
unknown. When bedside UVC placement is diffi-
cult, providers at our institution may opt to
abandon the procedure in favor of FGUVCP. This
selection bias would cause the FGUVCP success
rates to be artificially inflated. On the other hand,
it is conceivable that our patient population may
have other characteristics (term gestational age,
complex CHD, etc.) that may make bedside UVC
placement more difficult. For instance, in the
study by Al-Essa et al., when UVC placement was
attempted at <24 hours of life, the procedure was
successful in 17/18 (94.4%) of neonates <38 weeks
gestational age but only successful in 2/5 (40.0%)
of neonates ≥38 weeks gestational age.7 In our
study’s cohort, 75% of subjects had a gestational
age of ≥38 weeks conceivably making UVC place-
ment more difficult. Although a prospective study
would be necessary to truly delineate the degree to
which FGUVCP increases UVC utilization, a
study from our institution found that when UVC
placement was attempted in a cohort of single
ventricle patients, it was successful 83% of the
time.15 Thus, utilizing standard bedside placement
techniques and FGUVCP, the institutional success
rate for term patients with functional univentricu-
lar hearts, a population in which UVC placement
may be more difficult, is higher than the 75%
success rate that is reported in the literature for all
(but predominately premature) neonates.4–8
The importance of increasing UVC utilization
rates in neonates requiring congenital heart
surgery is clear. Many patients will require central
venous access, particularly femoral venous access,
for a wide range of future surgical and/or percuta-
neous interventions. The previously cited study by
Aiyagari et al. of neonates with single ventricle
heart disease serves as example to illustrate this
importance: the authors found lower rates of both
femoral venous thrombosis and iliofemoral venous
occlusion when initial line placement was a UVC
compared with those with femoral central venous
catheter.15 Given the increased absolute risk of
venous thrombotic disease in patients with femoral
lines in that study, the number of UVCs that need
to be placed in order to prevent one case of femoral
venous thrombosis and one case of iliofemoral
occlusion is three and four, respectively.15 Further-
more, while intravenous heparin infusion has been
shown to prevent thrombosis of central venous
catheters in children,16 this has been shown not to
be the case in infants after cardiac surgery.17 There-
fore, initial UVC placement is an attractive option
for our patients in order to increase the likelihood
of central venous patency.
Not unexpectedly, older age at the time of
FGUVCP was associated with an unsuccessful
procedure. While statistically significant, the clini-
cal significance of this finding is not clear. We
recommend that age should not be used as a cutoff
for deciding who should and who should not have
FGUVCP attempted. Age at procedure was avail-
able in 171 subjects and while those younger than
our optimal age cutoff of 20 hours did have suc-
cessful FGUVCP 82.4% of the time (75 of 91),
those at that cutoff or older still had successful
FGUVCP 67.5% of the time (54 of 80). Further,
the AUC for the ROC curve was low (0.61), which
is close to that of the line of no discrimination
(AUC = 0.5). Finally, although one should not base
clinical decisions based on the extreme cases, in
this series we documented ductus venosus closure
in an infant less than 5 hours old and successful
FGUVCP after 5 days of life.
We conclude, however, that these results should
impact institutional approaches to FGUVCP.
Given the higher success rates associated with the
20-hour age cutoff, our policy is to encourage
FGUVCP within the first 24 hours of life, irre-
spective of day of the week. This may not be fea-










(N = 92) (N = 22)
Procedure length, min 52.0 (39.9–72.8) 78.4 (58.1–90)
Fluoroscopy time, min
Total 3.2 (1.5–7.8) 5.6 (2.5–8.4)
AP 3.0 (1.1–6.4) 4.4 (2.2–6.9)
LAT 0.0 (0.0–0.9) 0.3 (0.0–1.2)
Contrast used, mL 1 (0–2) 2 (2–3)
0 28 (30.4) 0 (0.0)
0–2 30 (32.6) 3 (13.6)
2 20 (21.7) 11 (50.0)
≥3 14 (15.2) 8 (36.4)
Blood loss, mL 1 (1–2) 3 (2–5)
<1 15 (16.3) 0 (0.0)
1 36 (39.1) 2 (9.1)
2 19 (20.7) 5 (22.7)
≥3 21 (22.8) 15 (68.2)
Missing 1 (1.1) .
Complication 8 (8.7) 2 (9.1)
Data are presented as N (%) or median (25th–75th percentiles), as appropri-
ate.
FGUVCP, fluoroscopy-guided umbilical venous catheter placement.
DeWitt et al.322
Congenit Heart Dis. 2015;10:317–325
sible at all institutions, and the decision to devote
the resources needed to offer FGUVCP during
off-hours merits careful consideration.
Looking at other factors besides age, having a
functionally univentricular heart seemed to be
associated with FGUVCP being unsuccessful
though this association failed to reach statistical
significance. Again, the clinical significance is not
clear as this finding was surprising and we do not
have a satisfactory anatomical or physiological
explanation. Older gestational age also seemed to
be associated with FGUVCP failure. This finding
was less surprising. Because the ductus arteriosus
tends to persist longer in younger gestational age
neonates, it is reasonable to hypothesize the ductus
venosus may as well. However, the magnitude of
the difference seen between successful and failed
FGUVCP (median gestational age of 39 and 39.2
weeks, respectively) was not clinically significant.
We expected heterotaxy syndrome to be associated
with procedural failure, but the number of patients
with heterotaxy in our study was too small to reach
statistical significance. Anecdotally, patients with
heterotaxy syndrome can have an abnormally situ-
ated and tortuous ductus venosus making
FGUVCP difficult even if the ductus venosus is
patent.
We were unable to demonstrate an association
between prostaglandin infusion and ductus
venosus patency. This is likely because so many of
our patients were on prostaglandins at the time of
their procedure. The question of whether prosta-
glandin has a similar effect on the ductus venosus
as it does the ductus arteriosus is interesting and a
topic for future research.
While only 25% of patients in whom bedside
placement of UVCs was unsuccessful also had
failed FGUVCP, it would be advantageous if we
could identify this group prospectively, Identifying
ductus venosus closure at the bedside could lead to
fewer FGUVCP failures decreasing resource uti-
lization. Venous contrast echocardiography could
potentially aid in this. With the use of agitated
saline, venous contrast echocardiography has been
shown to identify atrial level shunts,18 pulmonary
arteriovenous malformations,19 and left superior
vena cava.20 It is conceivable that injecting agitated
saline into a “low-lying” UVC would show opaci-
fication of the atrial chamber(s) with microbubbles
if the ductus venosus was still patent, but the con-
trast would be filtered in the portal capillary
network resulting in no opacification of the heart
chambers if the ductus venosus was closed. This
has the potential for future research.
There are some important practical consider-
ations when performing FGUVCP. In patients in
whom bedside placement is unsuccessful, the “low-
lying” UVC is often the only source of venous
access prior to FGUVCP. This position would not
be considered central, so high doses of adrenergic
agents and high concentrations of parenteral nutri-
tion should be avoided. Further, if it is anticipated
that intravenous medication will be necessary
during the procedure (e.g., sedation, inotropic
support), a second site of venous access should be
obtained since the process of FGUVCP involves
removing the original catheter. In one patient who
was excluded from analysis, FGUVCP was never
attempted because there was no other venous
access and he was requiring frequent adenosine
doses for supraventricular tachycardia.
Another important consideration is how to
image the ductus venosus. We found that the
amount of lateral fluoroscopy exposure was low.
Indeed, in the 92 patients in whom only FGUVCP
was attempted, 52 (57%) patients had 0 minute of
lateral fluoroscopy exposure. However, the impor-
tance of the lateral imaging to visualize the ductus
venosus, which was described as early as 1969,21
cannot be overemphasized. This is especially true
in difficult cases as the ductus venosus takes a very
posterior course, which is difficult to appreciate by
frontal imaging.
Finally, we have demonstrated that this is a safe
procedure with minimal blood loss and exposure
to intravenous contrast and radiation. One major
complication occurred after the FGUVCP had
been completed. The causal relationship of secur-
ing the catheter to the respiratory arrest is unclear.
Two patients had transient arrhythmias which is
a known risk of intraatrial wire and catheter
manipulation. The other minor complications
involved inadvertent dislodgement of umbilical
arterial catheters. Generally, our neonatal critical
care team colleagues do not secure the umbilical
catheters with suture. Therefore, dislodgement of
the umbilical arterial catheter could potentially be
avoided if they are sutured to the umbilical stump
prior to transport.
Limitations of this study include its retrospec-
tive nature. A prospective study would be neces-
sary to truly understand the individual and
combined success rate of bedside UVC placement
and FGUVCP. Another limitation is the hetero-
geneity of cardiac diagnoses in this sample. The
number of subjects in each anatomic subgroup was
small. Lastly, there is individual variability among
cardiac interventionalists who perform this proce-
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dure. An institutional protocol could improve
case-by-case variability.
Conclusion
FGUVCP is a safe and relatively simple procedure
that can be performed readily in a pediatric cardiac
catheterization laboratory for patients in whom
bedside UVC placement was unsuccessful. In
patients with CHD, older age at the time of pro-
cedure is associated with FGUVCP failure.
However, we do not recommend withholding
FGUVCP from older neonates.
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